Y-mAbs Therapeutics Inc
(NASDAQ:YMAB)$6.21
0.24[4.02%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$6.21
0[0.00%]
After-Hours
| Open6.420 | Close6.210 |
| Vol / Avg.230.550K / 172.209K | Mkt Cap270.890M |
| Day Range6.200 - 6.790 | 52 Wk Range2.700 - 10.950 |
Y-mAbs Therapeutics Stock (NASDAQ:YMAB), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/13/2023 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $83.76M | Get Alert |
| 08/10/2023 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $82.79M | Get Alert |
| 11/07/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $51.75M | Get Alert |
| 08/08/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $60.18M | Get Alert |
| 04/27/2022 | YMAB | Y-mAbs Therapeutics | Q1 | 2022 | — | — | — | $10.50M | $10.50M | $10.99M | Get Alert |
| 04/27/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $67.81M | Get Alert |
What is the most recent guidance for Y-mAbs Therapeutics (YMAB)?
There have been no specific sales or earnings guidance reported for Y-mAbs Therapeutics in recent months.
Browse guidance and forecast on all stocks.